Literature DB >> 17149952

Histopathology of gastric and duodenal Strongyloides stercoralis locations in fifteen immunocompromised subjects.

Francesco Rivasi1, Silvio Pampiglione, Renzo Boldorini, Loredana Cardinale.   

Abstract

CONTEXT: Strongyloidiasis is a worldwide parasitic infection affecting approximately 75 million people. In Italy, it was more prevalent in the past among rural populations of irrigated areas.
OBJECTIVE: To determine the histopathologic alterations of the gastric and duodenal mucosa associated with the presence of Strongyloides stercoralis parasites.
DESIGN: Fifteen cases of strongyloidiasis were observed in immunocompromised patients during a recent 6-year period in Italy. S. stercoralis was found histologically in gastric biopsies (10 cases), in a gastrectomy (1 case), and in duodenal biopsies (9 cases). In 5 cases the parasite was present both in gastric and duodenal biopsies. Four patients were affected by lymphoma, 2 by multiple myeloma, 2 by gastric carcinoma, 1 by chronic myeloid leukemia, 1 by sideroblastic anemia, 1 by colorectal adenocarcinoma, 1 by chronic idiopathic myelofibrosis, 1 by chronic gastritis, 1 by gastric ulcers, and 1 by rheumatoid arthritis in corticosteroid therapy. No patient was affected by human immunodeficiency virus infection. Strongyloidiasis was not clinically diagnosed.
RESULTS: Histologic examination revealed several sections of S. stercoralis larvae, many eggs, and some adult forms. All the parasites were located in the gastric and/or the duodenal crypts. Eosinophils infiltrating into the lamina propria were found in all cases; their intensity was correlated with the intensity of the infection.
CONCLUSIONS: Histologic diagnosis of strongyloidiasis must be taken into consideration when examining both gastric and duodenal biopsies in immunocompromised patients, to avoid the development of an overwhelming infection of the parasite, which is dangerous for the life of the patient.

Entities:  

Mesh:

Year:  2006        PMID: 17149952     DOI: 10.5858/2006-130-1792-HOGADS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  9 in total

Review 1.  Strongyloidiasis: A Neglected Tropical Disease.

Authors:  Alejandro Krolewiecki; Thomas B Nutman
Journal:  Infect Dis Clin North Am       Date:  2019-03       Impact factor: 5.982

Review 2.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

Review 3.  Human and animal dirofilariasis: the emergence of a zoonotic mosaic.

Authors:  Fernando Simón; Mar Siles-Lucas; Rodrigo Morchón; Javier González-Miguel; Isabel Mellado; Elena Carretón; Jose Alberto Montoya-Alonso
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 4.  Human infection with Strongyloides stercoralis and other related Strongyloides species.

Authors:  Thomas B Nutman
Journal:  Parasitology       Date:  2016-05-16       Impact factor: 3.234

5.  Strongyloides stercoralis infection in the immunocompromised host.

Authors:  Roshan Ramanathan; Thomas Nutman
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 6.  The laboratory diagnosis and follow up of strongyloidiasis: a systematic review.

Authors:  Ana Requena-Méndez; Peter Chiodini; Zeno Bisoffi; Dora Buonfrate; Eduardo Gotuzzo; José Muñoz
Journal:  PLoS Negl Trop Dis       Date:  2013-01-17

7.  Colorectal Cancer Associated with Strongyloides stercoralis Colitis.

Authors:  Carmine Catalano; Joshua Aron; Raghav Bansal; Anatoly Leytin
Journal:  ACG Case Rep J       Date:  2017-08-30

Review 8.  Histologic features of colonic infections.

Authors:  Maria Westerhoff
Journal:  Pathologe       Date:  2021-11-12       Impact factor: 1.011

9.  Strongyloides stercoralis hyperinfection presenting with shock and intermittent eosinophilia: A case report.

Authors:  Jih Tze Tan; Chih-Wei Tseng
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.